Phase (approx.) Cagrilintide dose Frequency Weeks 14 0.25 mg Once weekly Weeks 58 0.5 mg Once weekly Weeks 912 1.0 mg Once weekly Weeks 1316 1.7 mg Once weekly Week 17 onward 2.4 mg (max studied) Once weekly This step-wise schedule mirrors the titration used in cagrilintide and CagriSema studies ( Lau et al., Lancet 2021
Medical studies suggest that glutathione levels may naturally decline with age, and various factors, including diet, lifestyle, and environmental exposures, may influence the body's glutathione production and utilization
10.1074/jbc.M609554200 44 TsujiiY.NishidaT.OsugiN.FujiiY.SugimotoA.NakamatsuD.et al (2022)
For example, the chronic traumatic encephalopathy experimental animal model cannot replicate the typical pathological features of human chronic traumatic encephalopathy: phosphorylation of tau protein and the formation of nerve fiber tangles
Nat Rev Gastroenterol Hepatol 21 , 335347 (2024)
The authors demonstrate that BPC-157 simultaneously heals cutaneous and internal wounds in various fistula models